首页> Current opinion in gastroenterology> Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

导出原文传递

翻译打印收藏纠错

第一作者： Kanai T

作者： Kanai T ^[1] ; Nemoto Y ; Kamada N

作者单位： Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. takagast ^[1]

关键词 Animals Cohort Studies Cytokines Disease Models Animal Drug Delivery Systems Homeostasis Immunologic Memory Immunosuppressive Agents Inflammatory Bowel Diseases Interleukin-17 Interleukin-7 Mice Inbred BALB C SCID Sensitivity and Specificity T-Lymphocytes Helper-Inducer Regulatory

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Current opinion in gastroenterology

2009年25卷4期

306-313页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览4

Current opinion in gastroenterology

2009年25卷4期

306-313页

检索历史清除

Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

Current opinion in gastroenterology

相似文献

同项目论文

Current opinion in gastroenterology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

Current opinion in gastroenterology

相似文献

同项目论文

Current opinion in gastroenterology

相关期刊

检索历史清除